Clinical Trial Update: Oritavancin for Treatment of Serious Cardiac Infections [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating oritavancin for serious cardiac infections, including infective endocarditis and cardiac device infection, with the study not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Device Infection
• Infective Endocarditis

Drugs mentioned

• Oritavancin (oritavancin)

Snippet

Sponsor: Kirby Institute | Conditions: Infective Endocarditis, Cardiac Device Infection | Phase 2 | Status: NOT_YET_RECRUITING